TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026 FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking recognizes the top-performing publicly listed companies in the United States that have demonstrated exceptional growth, financial stability, and stock performance over the past five years. According to TIME and Statista, thousands of businesses are founded i...
Occidental Announces Third Quarter 2025 Results HOUSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- (NYSE: OXY) today announced its third quarter 2025 financial results. The earnings release and accompanying financial schedules can be accessed via the section of the company’s website at . The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Tuesday, November 11, 2025, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (internati...
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CTKB) announced today that its has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. The annual program, conducted by leading independent market intelligence organization , recognizes innovative life sciences and biotechnology companies, products, and services worldwide. This year’s competition drew thousands of nominations from more than 15 countries. The award highlights Cytek’s commi...
Cytek Biosciences to Participate in Upcoming Investor Conferences FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Global Healthcare Conference in Palm Beach, FLParticipating in investor 1x1 meetings on Tuesday, November 11, 2025 Stephens NASH25 Investment Conference in Nashville, TNFireside chat on November 19, 2025, at 9:00 a.m. Pacific Time /12:00 p.m. Eastern Time Piper Sandler 37th Annual Healthcare Confer...
Cytek Biosciences Reports Third Quarter 2025 Financial Results FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Total revenue for the third quarter of 2025 was $52.3 million, representing a 2% increase compared to the third quarter of 2024Expanded to a total installed base of 3,456 Cytek instruments, adding 161 units in the third quarter of 2025Double-digit total revenue g...
Occidental Announces Dividend HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- (NYSE: OXY) announced today that its Board of Directors declared a regular quarterly dividend of $0.24 per share on common stock, payable on January 15, 2026, to stockholders of record as of the close of business on December 10, 2025. About Occidental is an international energy company with assets primarily in the United States, the Middle East and North Africa. We are one of the largest in the U.S., including a leading producer in the Permian and DJ basins, and offshore Gulf of America. Our provides flow assur...
James River Announces Third Quarter 2025 Results PEMBROKE, Bermuda, Nov. 03, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) reported a net loss from continuing operations available to common shareholders of $0.4 million, or ($0.01) per diluted share, compared to a net loss from continuing operations available to common shareholders of ($40.7 million), or ($1.07) per diluted share, for the same 2024 period. Adjusted net operating income1 for the third quarter of 2025 was $17.4 million or $0.32 per diluted share, compared to ($28.2 ...
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry Supports ISAC in Mission to Extend Flow Cytometry Reach Worldwide; Unveils Programs Offering Instrument Award and Research Grants FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, (Nasdaq: CTKB) is taking steps to ensure critical scientific research can continue. Joining the International Society for Advancement of Cytometry’s () mission to advance global availability and adoption of cyt...
American Assets Trust, Inc. Reports Third Quarter 2025 Financial Results Net income available to common stockholders of $4.5 million and $52.5 million for the three and nine months ended September 30, 2025, respectively, or $0.07 and $0.87 per diluted share, respectively. Funds from Operations ("FFO") of $0.49 and $1.53 per diluted share for the three and nine months ended September 30, 2025, respectively. Increased 2025 FFO per diluted share guidance to a range of $1.93 to $2.01 with a midpoint of $1.97, a $0.02 increase over prior guidance. SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) ...
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 FREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2025 after market close on Wednesday, November 5, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the “Investors” secti...
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth FREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that strengthens its European operations and enhances service for its customers, spectral flow cytometry leader (Nasdaq: CTKB) today announced the relocation of its European headquarters to a new facility in Amsterdam’s Life Sciences District. This relocation is an expansion, which reflects Cytek’s commitment to the EMEA region and highlights the company’s ongoing investment in delivering world-class solutions,...
James River to Hold Its Third Quarter Earnings Conference Call on Tuesday, November 4, 2025 PEMBROKE, Bermuda, Oct. 13, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) will release third quarter earnings after the market closes on Monday November 3, 2025. It will also host an earnings conference call on Tuesday, November 4, 2025 beginning at 9:00 a.m. (Eastern Time). The conference call may be accessed by dialing (800) 715-9871, conference ID 6910670, or via the investor website at . A replay will also be available in the same loc...
Occidental to Announce Third Quarter Results Monday, November 10, 2025; Hold Conference Call Tuesday, November 11, 2025 HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- (NYSE: OXY) will announce its third quarter 2025 financial results after close of market on Monday, November 10, 2025, and will hold a conference call to discuss the results on Tuesday, November 11, 2025, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at Participants may pre-register for the conference call at . Third...
James River Recruits Georgia Collier and Matt Sinosky, Completing E&S Leadership Reorganization PEMBROKE, Bermuda, Oct. 06, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) today announced the appointments of Georgia Collier and Matt Sinosky to its Excess and Surplus (“E&S”) leadership team, each reporting to Todd Sutherland, President of E&S. These two appointments support James River’s continued momentum to capture market opportunities and drive its next phase of profitable growth. With more than two decades of experience in the ...
Moody's Ratings (Moody's) said that Occidental Petroleum Corporation's (OXY, Baa3 stable) ratings and outlook are not affected by the sale of its chemical business (OxyChem). The sale is credit positive, with the planned debt reduction, lower leverage and improved credit metrics more than offsetting...
Occidental Promotes Richard A. Jackson to Senior Vice President and Chief Operating Officer HOUSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- (NYSE: OXY) announced today that its Board of Directors has promoted Richard A. Jackson to Senior Vice President and Chief Operating Officer, overseeing global oil and gas operations, low-carbon integrated technologies and the midstream and marketing and health, safety and environment functions. He will continue reporting to Vicki Hollub, President and Chief Executive Officer. Jackson was named Senior Vice President and President, U.S. Onshore Resources a...
American Assets Trust, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Information SAN DIEGO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its third quarter 2025 earnings in a press release to be issued after the market closes on Tuesday, October 28, 2025. Senior management will hold a conference call for its third quarter 2025 earnings on Wednesday, October 29, 2025 at 8:00 a.m. Pacific Time (“PT”). To access the conference call, please dial 1 (833) 816-1162 and ask to join the American Assets Trust,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.